LISTEN: Investors are betting $3.3 billion that your gut is the next frontier for the hottest part of healthcare
Samantha Lee/Business Insider
- Several high-profile startups that promised to draw insights from the bacteria living in and on us, known as the microbiome, have failed in recent months.
- One of them, a company called uBiome, which was valued at $600 million, said it would shut down on October 1 after months of challenges and setbacks.
- But investors still see the microbiome as a lucrative opportunity for the burgeoning digital-health industry, which has raked in $37.6 billion from investors since 2011.
- Here's how the microbiome companies they're betting on plan to succeed.
- Listen to this story below, or read it in full right here.
NOW WATCH: Why plane tires don't explode during landing
- Reddit recovers from a major outage as GameStop shares soar over 100%
- Nureca stocks debut on bourses at 54% premium over IPO price
- How Airtel’s AdTech platform is planning to deliver on the promise of ‘zero ad frauds’ to its clients
- Traffic jam on the Ganga - one of India's largest rivers will now get lane separators to deal with crowded boats
- Synology DiskStation DS220+ review – the perfect cloud replacement for backing up photos and files